BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28457692)

  • 1. Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes?
    Jones MS; Lee J; Stern SL; Faries MB
    J Am Coll Surg; 2017 Jul; 225(1):149-158. PubMed ID: 28457692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy and early-stage melanoma.
    Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
    Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of proliferative activity and tumor stage of pregnancy-associated melanoma (PAM) and non-PAM in gestational age women.
    Merkel EA; Martini MC; Amin SM; Yélamos O; Lee CY; Sholl LM; Rademaker AW; Guitart J; Gerami P
    J Am Acad Dermatol; 2016 Jan; 74(1):88-93. PubMed ID: 26545488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age.
    Tellez A; Rueda S; Conic RZ; Powers K; Galdyn I; Mesinkovska NA; Gastman B
    J Am Acad Dermatol; 2016 Apr; 74(4):731-8. PubMed ID: 26803345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
    Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
    Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma in pregnancy. A population-based evaluation.
    O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
    Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma.
    Fábián M; Rencz F; Krenács T; Brodszky V; Hársing J; Németh K; Balogh P; Kárpáti S
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1453-1461. PubMed ID: 28467693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes in pregnancy associated breast cancer: a retrospective case control study.
    Ali SA; Gupta S; Sehgal R; Vogel V
    Breast J; 2012; 18(2):139-44. PubMed ID: 22356297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in young women with cutaneous melanoma.
    Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
    Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
    Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Crookes TR; Scolyer RA; Lo S; Drummond M; Spillane AJ
    Ann Surg Oncol; 2017 May; 24(5):1378-1385. PubMed ID: 28130620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pregnancy on survival in women with cutaneous malignant melanoma.
    Lens MB; Rosdahl I; Ahlbom A; Farahmand BY; Synnerstad I; Boeryd B; Newton Bishop JA
    J Clin Oncol; 2004 Nov; 22(21):4369-75. PubMed ID: 15514378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma and pregnancy.
    Reintgen DS; McCarty KS; Vollmer R; Cox E; Seigler HF
    Cancer; 1985 Mar; 55(6):1340-4. PubMed ID: 3971302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pregnancy in stage I melanoma.
    Wong JH; Sterns EE; Kopald KH; Nizze JA; Morton DL
    Arch Surg; 1989 Oct; 124(10):1227-30; discussion 1230-1. PubMed ID: 2802988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent melanoma: risk factors and long term survival.
    Daryanani D; Plukker JT; Nap RE; Kuiper H; Hoekstra HJ
    Eur J Surg Oncol; 2006 Mar; 32(2):218-23. PubMed ID: 16412599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Analysis of Clinicopathological Characteristics of Pregnancy Associated Melanoma.
    Fábián M; Tóth V; Somlai B; Hársing J; Kuroli E; Rencz F; Kuzmanovszki D; Szakonyi J; Tóth B; Kárpáti S
    Pathol Oncol Res; 2015 Sep; 21(4):1265-71. PubMed ID: 26177701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma and pregnancy.
    Silipo V; De Simone P; Mariani G; Buccini P; Ferrari A; Catricala C
    Melanoma Res; 2006 Dec; 16(6):497-500. PubMed ID: 17119450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Prognostic Markers in Stage IIIB Melanoma.
    Madu MF; Wouters MW; Klop WM; van der Hiel B; van de Wiel BA; Jóźwiak K; van der Hage JA; van Akkooi AC
    Ann Surg Oncol; 2016 Dec; 23(13):4195-4202. PubMed ID: 27380642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.